Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155987 | SCV000205699 | uncertain significance | not specified | 2018-09-06 | criteria provided, single submitter | clinical testing | proposed classification - variant undergoing re-assessment, contact laboratory |
Labcorp Genetics |
RCV000686624 | SCV000814150 | pathogenic | Hypertrophic cardiomyopathy | 2022-11-14 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MYH7 protein function. ClinVar contains an entry for this variant (Variation ID: 179201). This missense change has been observed in individuals with hypertrophic cardiomyopathy (PMID: 26743238, 27532257; Invitae). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 1386 of the MYH7 protein (p.Leu1386Phe). |
CHEO Genetics Diagnostic Laboratory, |
RCV003486703 | SCV004239466 | uncertain significance | Cardiomyopathy | 2023-03-06 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001249250 | SCV001423189 | not provided | Primary dilated cardiomyopathy; Hypertrophic cardiomyopathy 1; Myosin storage myopathy; Left ventricular noncompaction | no assertion provided | phenotyping only | Variant interpretted as Uncertain significance and reported on 01-30-2019 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. |